Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.2450 (2.04%) ($3.0500 - $3.2450) on Wed. Apr. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.78% (three month average) | RSI | 56 | Latest Price | $3.2450(2.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.6% a day on average for past five trading days. | Weekly Trend | CGEN advances 0.3% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) SPY(93%) IVW(92%) XBI(91%) XLK(91%) IWO(90%) | Factors Impacting CGEN price | CGEN will decline at least -1.89% in a week (0% probabilities). VXX(-95%) UNG(-29%) TIP(-19%) UUP(-16%) TBT(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.89% (StdDev 3.78%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $3.25(-0.15%) | 10 Day Moving Average | $3.27(-0.76%) | 20 Day Moving Average | $3.21(1.09%) | To recent high | -24% | To recent low | 18% | Market Cap | $268m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |